Antibe Therapeutics (Antibe Therapeutics Stock Quote, Chart, News TSXV:ATE) has had a turbulent coup... Read More
Investment bankers Paradigm Capital launched coverage on Wednesday of drug developer Antibe Therapeu... Read More
Antibe Therapeutics (Antibe Therapeutics Stock Quote, Chart, News TSXV:ATE) has performed well both ... Read More
Canadian Life Sciences stocks have been on a roller coaster ride so far in 2019. The sector, which i... Read More
Echelon Wealth Partners analyst Douglas Loe is holding steady on his investment thesis for clinical ... Read More
Echelon Wealth Partners analyst Douglas Loe is staying bullish on clinical stage drug developer Anti... Read More
Share
Tweet
pin
Share